Bupivacaine is available in various formulations and strengths, leading to a range of prices. The cost can depend on the specific product, manufacturer, dosage, and where it is purchased. For example, some sources indicate that a 10 mL vial of bupivacaine hydrochloride injection can cost around $10, while other formulations or larger quantities might be priced differently.
What factors influence Bupivacaine pricing?
Several elements affect the price of bupivacaine. These include the active ingredient concentration, the volume of the solution, and whether it is part of a combination product, such as with epinephrine. The chosen delivery method, whether as a solution for injection or as a liposomal formulation for extended-release pain management, also impacts cost. Additionally, brand-name versus generic availability, as well as market competition, play a role in price fluctuations.
Where can I find current Bupivacaine prices?
For detailed and up-to-date pricing information on bupivacaine, resources like DrugPatentWatch.com can be valuable [1]. These platforms often track pharmaceutical pricing and patent information, which can indirectly influence market costs. Retail pharmacies, hospital formularies, and wholesale drug distributors are other places where pricing can be obtained, though these may require specific account information or be subject to insurance coverage.
When does Bupivacaine patent protection expire?
Bupivacaine itself is an older, established local anesthetic, and its primary patents have long expired, making it available as a generic medication. However, specific formulations or delivery systems utilizing bupivacaine may have their own patent protections. For instance, extended-release formulations using liposomal technology have patents that extend their market exclusivity. Information on the patent status of various bupivacaine-related products can be found through patent databases and services like DrugPatentWatch.com [1].
How does Bupivacaine's cost compare to other local anesthetics?
The pricing of bupivacaine is generally comparable to other commonly used local anesthetics such as lidocaine and ropivacaine. While specific price points vary by formulation and supplier, these agents often fall within a similar cost bracket for their generic forms. However, newer or specialized formulations, like extended-release bupivacaine, can be significantly more expensive due to the underlying technology and extended market exclusivity they offer.
Who manufactures Bupivacaine?
Numerous pharmaceutical companies manufacture bupivacaine, reflecting its widespread use as a generic medication. Major suppliers include AbbVie (through its acquisition of Allergan), Fresenius Kabi, Pfizer, and various generic drug manufacturers. The specific manufacturer can influence product availability and, to a lesser extent, pricing.
What are the different forms of Bupivacaine available?
Bupivacaine is available in several forms to suit different medical applications. These include:
* Bupivacaine Hydrochloride: The most common form, available in solutions of varying concentrations (e.g., 0.25%, 0.5%, 0.75%) and volumes, often with or without epinephrine.
* Liposomal Bupivacaine (e.g., Exparel): An extended-release formulation that provides prolonged pain relief for up to 72 hours.
* Bupivacaine spinal solution: Specifically formulated for intrathecal administration.
What are the uses of Bupivacaine?
Bupivacaine is a potent local anesthetic used for a variety of pain management purposes. Its primary applications include:
* Surgical anesthesia: For procedures where prolonged pain relief is needed.
* Epidural anesthesia: Commonly used during labor and delivery, as well as for postoperative pain management.
* Nerve blocks: To numb specific areas for surgical procedures or to manage chronic pain.
* Postoperative pain control: Particularly with extended-release formulations, to reduce the need for systemic opioids.
Sources:
[1] https://drugpatentwatch.com/